| 23 whitepaper results |
|
-
Why do we actually need to monitor Biobanking Facilities? There are several reasons for that: You have to ensure the sample integrity and to document the storage conditions. Another point is the required compliance with national and international regulations e.g. FDA Good Tissue Practice (GTP), FDA Good Storage Practice (GSP). Furthermore a monitoring allows you an early detection of trends in environmental conditions and to respond proactively and to raise alarms and warnings in case of adverse events e.g. temperature deviation. learn more
biobanking | elpro | sample management | gsp | gtp | fda | storage | monitoring
-
GDP guidelines in one single place! As there is no single global GDP standard, Cold Chain IQ has created this easy to-assimilate summary of GDP requirements around the world, enabling you to navigate the landscape learn more
GDP | GDP Guidelines | Almac | global GDP guidelines | GDP standard | Good Distribution Practice
-
NEW for 2012: Pharma IQ has updated this easy-to-assimilate summary of serialisation requirements around the world, whether they are already being followed or have impending deadlines (e.g. much of Europe due to the Falsified Medicines Act). You can keep it as a handy reference, share it around your colleagues or even stick it on your wall! learn more
pharmaceutical serialisation deadlines | latest serialisation developments | Falsified Medicines Act | EFPIA | GS1 | pharma serialisation deadlines | pharma traceability
-
Pharma IQ in conjunction with the 3rd Annual Clinically Relevant Drug Transporters presents this Global Guide to Drug Transporters, the definitive resource for professionals in the drug transportation area. The guide summarizes the key issues related to drug transporters outsourcing, new drug delivery technologies and the expected progress in 2013. learn more
-
Despite global cost-cutting initiatives, over 82% of those working in the capacity of distribution expect their vendor investment budget to increase over the next 2 years learn more
Pharmaceutical Distribution | Distribution | Supply Chain | Logistics
-
Understanding the buying patterns of your customers in an uncertain economic climate is crucial to remain competitive. Need to know what pharmaceutical and biotech key decision makers are prioritising and investing in? The results are in 52% of key decision makers are looking to meet track & trace service providers. For more key findings download the infographic now! learn more
packaging and labelling | pharmaceutical packaging | Global Pharmaceutical Packaging Investment Forecast | pharmaceutical and biotech key decision makers | packaging industry | pharmaceutical packaging leaders | serialisation | authentication providers
-
Provided by Nice Insight, this quick guide will enable you to target customers by the services they will outsource in 2012. learn more
biotech | emerging biotech | pharma | specialty pharma | emerging pharma | outsourcing | pharmaceutical outsourcing
-
Although outsourcing is a growing trend in higher and middle income countries, it’s an emerging trend in lower income country settings. Although there are clear theoretical benefits, the true costs and benefits of doing so are not well documented, nor is there a good understanding of the challenges of outsourcing public health supply systems and what conditions are necessary conditions for outsourcing to be successful. The review of the Western Cape Province experience is a small incremental step towards filling this information gap. learn more
vaccine supply | South Africa | logistics system | public health supply systems | outsourcing public health supply systems | cold chain
-
The introduction of new vaccines, combined with a push to expand immunisation globally to reach every child, is straining vaccine supply chains to the limit. New thinking on the way vaccines are delivered is needed. Gary Humphreys reports learn more
vaccine supply chains | vaccines | immunisation globally | WHO | supply chain | pharma supply chain
-
This paper documents the poor availability of various Essential Health Product (EHPs) s in Africa and explores how to improve EHP distribution via collaborations with the private sector. learn more
Essential Health Product | EHPs | EHP distribution | EHP availability | pharma logistics | cold chain | access to essential medicines | pharmaceutical supply chain | International Vaccine Access Center | IVAC
-
In this document, project Optimize reviews the US Centers for Disease Control and Prevention’s (CDC’s) Vaccine Management Business Improvement Project, which represents an end-to-end reengineering of the US public-sector vaccine supply chain—from vaccine budgeting through storage and distribution. The CDC’s overarching goal was to ensure that vaccine was flowing to the right places at the right time. learn more
project Optimize | vaccine budgeting | vaccine storage | US Centers for Disease Control and Prevention | CDC | Vaccine Management Business Improvement Project | US public-sector vaccine supply chain
| 23 whitepaper results |
|
-
Compound Management & Integrity Online 2011
November 14, 2011
Register Now -
Regenerative Medicine and Barriers to Commercialisation Online Summit 2011
October 25, 2011
Register Now -
Electronic Laboratory Notebooks Online
December 2, 2011
Register Now -
Drive Successful Commercial Product Launches through Effective Key Packaging
February 7, 2013
Register Now




Not a member? Sign Up
Reasons for Joining
Address your challenges through knowledge sharing with peers from our global network of specialists.
Benchmark your business initiatives with the who's who in the field.
Hear from industry pioneers how to maximize ROI in today's challenging economy.
And best of all It's FREE!